SuperworthMilestone Scientific profit margin MLSS
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −44.0%
- Operating margin, 12 months
- −43.6%
- Net margin on a year earlier
- +32.8 pts
- Peer median
- 8.4%
Over the twelve months to Jun 30, 2026, Milestone Scientific kept −44.0% of its revenue as net profit, with an operating margin of −43.6% and a gross margin of 70.2%.
Five years earlier its net margin was −70.7%.
The median for 5 medical instruments and supplies stocks of a similar size is 8.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −63.8% | −63.5% | 71.4% |
| FY2024 | −54.6% | −78.3% | 74.6% |
| FY2023 | −70.5% | −72.3% | 69.1% |
| FY2022 | −98.9% | n/a | 55.7% |
| FY2021 | −66.2% | −71.6% | 61.3% |
| FY2020 | n/a | n/a | 67.2% |
| FY2019 | −89.8% | −47.8% | 68.3% |
| FY2018 | −77.2% | −83.1% | 46.0% |
| FY2017 | −46.0% | −46.4% | 61.8% |
| FY2016 | −54.3% | −59.8% | 60.7% |
| FY2015 | −57.6% | −32.2% | 67.9% |
| FY2014 | −16.5% | −7.6% | 64.9% |
| FY2013 | 14.6% | 10.9% | 68.0% |
| FY2012 | −10.1% | −6.0% | 64.7% |
| FY2011 | −17.7% | −14.6% | 64.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −44.0% | +32.8 pts | −43.6% | |
| Q1 FY26 | −51.3% | +9.9 pts | −50.8% | |
| Q4 FY25 | −63.8% | −9.1 pts | −63.5% | |
| Q3 FY25 | −74.7% | −22.7 pts | −74.6% | |
| Q2 FY25 | −76.8% | −21.9 pts | −77.0% | |
| Q1 FY25 | −61.2% | +13.3 pts | −84.6% | |
| Q4 FY24 | −54.6% | +15.9 pts | −78.3% | |
| Q3 FY24 | −52.0% | +19.0 pts | −75.4% | |
| Q2 FY24 | −54.9% | +20.1 pts | −79.9% | |
| Q1 FY24 | −74.5% | +18.7 pts | −76.3% | |
| Q4 FY23 | −70.5% | +28.4 pts | −72.3% | |
| Q3 FY23 | −71.0% | +12.4 pts | −72.8% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Milestone Scientific's size, closest first, today.
| Company | Profit margin |
|---|---|
| MLSSMilestone Scientific | −44.0% |
| NEPHNephros | 8.4% |
| APTAlpha Pro Tech | 6.8% |
| KEQUKewaunee Scientific | 3.0% |
| PDEXPro DEX | 17.6% |
| UTMDUtah Medical Products | 29.0% |
| Peer median | 8.4% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Milestone Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.